Mode | Project ID | Indication | Hit Generation | Hit to Lead | Lead Optimization | IND-Enabling | Phase 1 | |
---|---|---|---|---|---|---|---|---|
Activator | PTT-001 | I-O | ||||||
PTT-009 | I-O | |||||||
PTT-007 | I-O | |||||||
Gene Modulation | PTT-008 | I-O | ||||||
Inhibitor | PTT-003 | Chemotherapy Associated Adverse Effect such as CIPN CNS Diseases Kidney Diseases Atherosclerosis |
||||||
PTT-004,005 | Gain function auto-inflammatory Diseases IBD |
|||||||
PTT-002 | Sepsis | |||||||
PTT-006 | Asthma |
PTT-001 | I-O | |
PTT-009 | I-O | |
PTT-007 | I-O | |
PTT-008 | I-O | |
PTT-003 | Chemotherapy Associated Adverse Effect such as CIPN CNS Diseases Kidney Diseases Atherosclerosis |
|
PTT-004,005 | Gain function auto-inflammatory Diseases IBD |
|
PTT-002 | Sepsis | |
PTT-006 | Asthma | |